510(k) Report

510(k) · Cleared

Cleared

HMS-DHR-3 Neuromuscular Stimulator

K021496510(k) TraditionalCleared Aug 6, 200289-day reviewClass II21 CFR 882.5890

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Home Medical Services · GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

Cleared on Aug 6, 2002 after an 89-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 3 later devices descend from it.

Decided
Aug 6, 2002
Review
89 days
Class
Class II
Product code
GZJ
Recalls
None
Predicates
0

3 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2011: 1 descendant cleared2014: 1 descendant cleared2016: 1 descendant cleared200020052010201520202025
  1. This deviceK021496 HMS-DHR-3 Neuromuscular StimulatorHome Medical Services · 2002
  2. Descendant · cites it directly · 2 of its ownK112485 H-WAVEElectronic Waveform Lab, Inc. · 2011
  3. Descendant · 2 generations on · 1 of its ownK131910 MPPMarc Pro · 2014
  4. Descendant · 2 generations on · 0 of its ownK160255 HBOTC Muscle and Nerve StimulatorHb Medical, Inc. · 2016

Most influential descendants

Showing 3 of 3 · See all
  • K112485H-WAVEElectronic Waveform Lab, Inc. · 2011 · cites it directly2descendants
  • K131910MPPMarc Pro · 2014 · 2 generations on1descendant
  • K160255HBOTC Muscle and Nerve StimulatorHb Medical, Inc. · 2016 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K021496HMS-DHR-3 Neuromuscular StimulatorHome Medical Services2002—
+1K112485H-WAVEElectronic Waveform Lab, Inc.2011—
+2K131910MPPMarc Pro2014—
+2K160255HBOTC Muscle and Nerve StimulatorHb Medical, Inc.2016—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201110
201410
201610
FIG. 1 — Lineage of K021496, 2002–2016Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GZJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GZJ device

  1. #1 K252767 actiTENS miniscore 13.1 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it? (3)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K112485H-WAVEElectronic Waveform Lab, Inc.20112

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K112485 (Electronic Waveform Lab, Inc., 2011) has gone furthest, with 2 descendants of its own.

How does its category compare?

All GZJ devices

GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GZJ

1in 2025

2007: 132008: 112009: 162010: 52011: 52012: 122013: 22014: 42015: 32016: 32017: 32018: 22019: 32020: 42021: 32022: 42023: 12024: 32025: 12026 (partial year): 2
2007high 16 (2009) · low 1 (2023)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GZJ

207in 2024

2007: 223 days median2008: 136 days median2009: 155 days median2010: 232 days median2011: 168 days median2012: 154 days median2014: 344 days median2015: 202 days median2016: 163 days median2017: 113 days median2019: 156 days median2020: 183 days median2021: 231 days median2022: 175 days median2024: 207 days median
2007high 344 (2014) · low 113 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GZJ

1in 2011

2007: 42008: 12011: 1
2007high 4 (2007) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GZJ

13in 2025

2007: 42008: 452009: 172010: 222011: 222012: 202013: 102014: 232015: 182016: 322017: 582018: 212019: 72020: 102021: 52022: 42023: 392024: 122025: 13
2007high 58 (2017) · low 4 (2007)2025

MAUDE reports naming product code GZJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071322344
200811136145
200916155017
20105232022
20115168122
201212154020
20132—010
20144344023
20153202018
20163163032
20173113058
20182—021
2019315607
20204183010
2021323105
2022417504
20231—039
20243207012
20251—013
20262—0—

What is it indicated for?

SYMPTOMATIC RELIEF OF CHRONIC INTRACTABLE PAIN

Indications for use as stated in the FDA 510(k) statement.

Cite this page

510(k) Report. “K021496: HMS-DHR-3 Neuromuscular Stimulator.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K021496

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026